Review Article
Year: 2019 | Month: November | Volume: 6 | Issue: 11 | Pages: 44-51
Infant Cancer Chemotherapy
Chandhni ES1, Sujitha PJ1, Sambathkumar R2
Pharm D Student, Lecturer
1Department of Pharmacy Practice, 2Department of pharmaceutics,
J.K.K. Nattraja College of Pharmacy,Kumarapalayam-638183, Tamil Nadu, India
Corresponding Author: Sujitha PJ
ABSTRACT
Cancer is the abnormal, excessive, uncoordinated, autonomous and purposeless proliferation of cells even after the cessation of stimulus for growth which caused it. Cancer occurring in infants often has both clinical and biological properties that are different from those of the same histologic type of cancer diagnosed in older patients. Infant cancers tend to be more aggressive and progresses more rapidly than adult cancers. But with some exceptions, infant cancers respond better to certain treatment than adult cancers do. Worldwide, it is estimated that infant cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. Infant cancers are not always treated like that of adult cancers. Pediatric oncology is a medical specialty focused on the care of children with cancer. In developed countries, infant cancer has a mortality of approximately 20% of cases. In low resource settings, on the other hand, mortality is approximately 80% or even 90% in the world's poorest countries. In many developed countries the incidence is increasing at a faster rate each year.
Key words: cancer, chemotherapy, oncology.
[PDF Full Text]